Gamma-irradiated cornea allograft is safe and effect for use in glaucoma surgery, according to a paper published in the latest issue of the Journal of Glaucoma.
News
The incidence of retinal haemorrhages in abusive head trauma in paediatric patients for known perpetrators, regardless of a confession, is similar, reveals a paper.
The acrylic angle-supported phakic IOL (PIOL) provides moderate one-year rotational stability, making it a successful treatment option for myopic eyes, claims a new paper.
Aflibercept 2.0 mg may be beneficial for cases of exudative AMD unsuccessfully treated with ranibizumab or bevacizumab, according to a recent retrospective review.
Ocular toxocariasis can cause cataract with opacity similar to granuloma, claim recent findings published in the Journal of Cataract and Refractive Surgery.
Nicox has joined forces with Immco Diagnostics to offer tests for the early detection of Sjögren's syndrome.
Wavelet augmented ultrasound effectively detects differences in choroidal microarchitecture in eyes with wet and dry AMD, according to a recent paper.
The International Glaucoma Association (IGA) will be awarding five grants totaling ?255 000 for critical glaucoma research.
The refreshed UK Vision Strategy was launched at the Vision UK 2013 Conference, according to a press statement.
Researchers at the University of Nottingham, UK, have announced their discovery of a previously undetected layer in the cornea, the clear window at the front of the human eye.
A new implant that allows patients suffering from advanced age-related macular degeneration (AMD) to improve their general vision and regain independence is now being implanted in the UK.
The foldable glued-IOL technique provides satisfactory and safe visual outcomes, claims a paper in the latest issue of the Journal of Cataract and refractive Surgery.
Repeated pars plana vitrectomy, with internal limiting membrane peeling and gas tamponade, is a safe and effective treatment technique for persistent macular holes, states an investigation in the Journal of Retinal and Vitreous Diseases.
With-the-rule astigmatism (WTA) reduces reading parameters and near visual acuity (NVA) compared with against-the-rule astigmatism (ATR) and no astigmatism, according to a recent paper.
Cocaine-assisted epithelial debridement is a simple and inexpensive treatment method for symptomatic anterior basement membrane dystrophy (ABMD) patients, reveals the latest study in the journal Cornea.
Long-term positive outcomes of a minimally invasive retrobulbar episcleral brachytherapy device (SalutarisMD, Salutaris Medical Devices, London, UK) show promise for treating wet age-related macular degeneration (wAMD), according to data presented at the RCO congress.
JETREA (ThromboGenics, Leuven, Belgium) has launched in Denmark and Sweden with roll out of the drug to follow shortly in Finland and Norway. These launches will be performed by ThromboGenics partner, Alcon.
Primary endpoint results, demonstrating the non-inferiority of the BIOTRONIK Orsiro hybrid drug-eluting stent compared to Abbott?s XIENCE PRIME, from the BIOFLOW-II clinical study have been revealed at the EuroPCR congress in Paris.
The National Institute for Health and Care Excellence (NICE) has announced that Eylea (aflibercept, Bayer HealthCare, Leverkusen, Germany) should be recommended for the treatment of patients with wet age related macular degeneration (wAMD).
Comparative study results support use of once-daily treatment, but both satisfactory
A round-up of the latest ophthalmic products
An exciting new option in combination with cataract surgery
Positioning the ExPRESS shunt in the glaucoma surgeon's practice
Procedure has ability to lower IOP, preserve vision similar to trabeculectomy and tube shunts
Moderately cohesive ophthalmic viscosurgical devices offer desired performance traits
Ability to observe details of deep retinal structures noninvasively and clearly
Using an anatomically accurate OCT-derived neuroretinal rim parameter
Investigating tolerability of a diagnostic device in healthy and glaucomatous patients
The rationale for optimizing the ocular surface in glaucoma patients
Advertisement
Advertisement
